Refrence:
[1] 孙凯,魏戌,朱立国,等.病证结合模式下骨质疏松症实验动物模型的研究进展[J].中国骨质疏松杂志,2019.DOI:CNKI:SUN:ZGZS.0.2019-09-028.
[2] 江瑞雪,蒋欣泉,文晋.骨质疏松动物模型研究现状与进展[J].中国骨质疏松杂志,2022(007):028.
[3] Hendrickx G, Boudin E, Van Hul W. A look behind the scenes: the risk and pathogenesis of primary osteoporosis. Nat Rev Rheumatol. 2015;11(8):462-474. doi:10.1038/nrrheum.2015.48
[4] Lei C, Song JH, Li S, et al. Advances in materials-based therapeutic strategies against osteoporosis. Biomaterials. 2023;296:122066. doi:10.1016/j.biomaterials.2023.122066
[5] 祁珊珊.骨质疏松疾病动物模型的研究进展[J].黑龙江畜牧兽医,2016(5):3.DOI:10.13881/j.cnki.hljxmsy.2016.0776.
[6] Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115-137. doi:10.1210/edrv.21.2.0395
[7] Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020;16(8):437-447. doi:10.1038/s41574-020-0341-0
[8] Boudin E, Van Hul W. MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation. Eur J Endocrinol. 2017;177(2):R69-R83. doi:10.1530/EJE-16-0990
[9] Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364-376. doi:10.1016/S0140-6736(18)32112-3